Tafere Mulaw Belete. (2023) Recent Progress in the Development of New Antiepileptic Drugs with Novel Targets. Annals of Neurosciences 30:4, pages 262-276.
Crossref
Carla LoPinto-Khoury. (2022) Long-Term Effects of Antiseizure Medications. Seminars in Neurology 42:05, pages 583-593.
Crossref
Rushelle Byfield & Lawrence Copelovitch. 2022. Diagnosis and Management of Pediatric Nephrolithiasis. Diagnosis and Management of Pediatric Nephrolithiasis
65
75
.
Alberto Verrotti, Simona Lattanzi, Francesco Brigo & Gaetano Zaccara. (2020) Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice. Epilepsy & Behavior 104, pages 106939.
Crossref
Linda J. Stephen & Martin J. Brodie. (2020) Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults. CNS Drugs 34:2, pages 147-161.
Crossref
Maria Chiara Sighinolfi, Ahmed Eissa, Luigi Bevilacqua, Ahmed Zoeir, Silvia Ciarlariello, Elena Morini, Stefano Puliatti, Viviana Durante, Pier Luca Ceccarelli, Salvatore Micali, Giampaolo Bianchi & Bernardo Rocco. (2019) Drug-Induced Urolithiasis in Pediatric Patients. Pediatric Drugs 21:5, pages 323-344.
Crossref
. (2018) Be aware of the risk of drug-induced kidney stones and take appropriate steps to prevent or treat their occurrence. Drugs & Therapy Perspectives 35:2, pages 64-70.
Crossref
Mark A. Perazella. (2018) Pharmacology behind Common Drug Nephrotoxicities. Clinical Journal of the American Society of Nephrology 13:12, pages 1897-1908.
Crossref
Michel Daudon, Vincent Frochot, Dominique Bazin & Paul Jungers. (2017) Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment. Drugs 78:2, pages 163-201.
Crossref
Adam D. Simmons. 2018. Integrative Medicine. Integrative Medicine
143
151.e3
.
Martin J Brodie. (2017) Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician’s Overview. CNS Drugs 31:2, pages 135-147.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
597
660
.
Elizabeth Harvey & Walid A. Farhat. 2016. Pediatric Kidney Disease. Pediatric Kidney Disease
1135
1191
.
. 2015. The Treatment of Epilepsy. The Treatment of Epilepsy
680
688
.
Yasmin Idu Jion, Amanda Raff, Brian M. Grosberg & Randolph W. Evans. (2015) The Risk and Management of Kidney Stones From the Use of Topiramate and Zonisamide in Migraine and Idiopathic Intracranial Hypertension. Headache: The Journal of Head and Face Pain 55:1, pages 161-166.
Crossref
Uma Menon & Ilo E. Leppik. 2015. Seizures in Cerebrovascular Disorders. Seizures in Cerebrovascular Disorders
121
132
.
J. Helen Cross, Stéphane Auvin, Anna Patten & Luigi Giorgi. (2014) Safety and tolerability of zonisamide in paediatric patients with epilepsy. European Journal of Paediatric Neurology 18:6, pages 747-758.
Crossref
Michel Daudon & Paul Jungers. 2014. Urinary Stones. Urinary Stones
106
119
.
Sheridan M. Hoy. (2013) Zonisamide: A Review of Its Use in the Management of Adults with Partial Seizures. Drugs 73:12, pages 1321-1338.
Crossref
Athanasios Gaitatzis & Josemir W. Sander. (2013) The Long-Term Safety of Antiepileptic Drugs. CNS Drugs 27:6, pages 435-455.
Crossref
Adam D. Simmons. 2012. Integrative Medicine. Integrative Medicine
122
130.e2
.
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
461
479
.
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
395
418
.
M.L. Miller, S.A. Center, J.F. Randolph, M.L. Lepherd, M.A. Cautela & C.W. Dewey. (2011) Apparent Acute Idiosyncratic Hepatic Necrosis Associated with Zonisamide Administration in a Dog. Journal of Veterinary Internal Medicine 25:5, pages 1156-1160.
Crossref
Yuriko Tanaka, Yoshiko Abe, Yuji Oto, Hisashi Itabashi, Nobuyuki Murakami, Ryouichi Sakuta & Toshiro Nagai. (2011) Five cases of West syndrome complicated by nephrocalcinosis during combination therapy with ACTH and zonisamide. Nihon Shoni Jinzobyo Gakkai Zasshi 24:1, pages 86-91.
Crossref
Elahna Paul, Kerry D. Conant, Irie E. Dunne, Heidi H. Pfeifer, David A. Lyczkowski, Michael A. Linshaw & Elizabeth A. Thiele. (2010) Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy. Epilepsy Research 90:1-2, pages 151-156.
Crossref
Ilo E. Leppik & Angela K. Birnbaum. (2010) Epilepsy in the elderly. Annals of the New York Academy of Sciences 1184:1, pages 208-224.
Crossref
Gaetano Zaccara. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
123
182
.
Michel Daudon & Paul Jungers. 2011. Urinary Tract Stone Disease. Urinary Tract Stone Disease
225
237
.
Mark A. Perazella. (2009) Renal Vulnerability to Drug Toxicity. Clinical Journal of the American Society of Nephrology 4:7, pages 1275-1283.
Crossref
Pedro Emilio Bermejo & Rodolfo Dorado. (2009) Zonisamide for Migraine Prophylaxis in Patients Refractory to Topiramate. Clinical Neuropharmacology 32:2, pages 103-106.
Crossref
Nicholas M Wallingford, Puspha Sinnayah, Frank P Bymaster, Kishore M Gadde, Ranga K Krishnan, Anthony A McKinney, Ronald P Landbloom, Gary D Tollefson & Michael A Cowley. (2008) Zonisamide Prevents Olanzapine-Associated Hyperphagia, Weight Gain, and Elevated Blood Glucose in Rats. Neuropsychopharmacology 33:12, pages 2922-2933.
Crossref
S. J. Wroe, A. B. Yeates & A. Marshall. (2008) Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy. Acta Neurologica Scandinavica 118:2, pages 87-93.
Crossref